Kimberly Blumenthal

We were trying so hard. I was working with Thermo Fisher Scientific. They have developed a blood test panel, and they wanted to see if it worked in allergic individuals from America. We identified in the Boston area everyone that reacted to penicillin in front of our faces in the last few years. We sent them the blood of these individuals, and I think it picked up like three.

We were trying so hard. I was working with Thermo Fisher Scientific. They have developed a blood test panel, and they wanted to see if it worked in allergic individuals from America. We identified in the Boston area everyone that reacted to penicillin in front of our faces in the last few years. We sent them the blood of these individuals, and I think it picked up like three.

It was like three of 20. It didn't pick it up yet.

It was like three of 20. It didn't pick it up yet.

It was like three of 20. It didn't pick it up yet.

The conclusion was, well, they were allergic in the last 5, 10 years. Maybe they weren't allergic now. So I have to bring them back, retest them. And then these patients, they're like needles in haystacks, right? We combed the records of all Mass General Brigham to find these 22 penicillin allergics. We really need to say, OK, you reacted to penicillin in front of my face today.

The conclusion was, well, they were allergic in the last 5, 10 years. Maybe they weren't allergic now. So I have to bring them back, retest them. And then these patients, they're like needles in haystacks, right? We combed the records of all Mass General Brigham to find these 22 penicillin allergics. We really need to say, OK, you reacted to penicillin in front of my face today.

The conclusion was, well, they were allergic in the last 5, 10 years. Maybe they weren't allergic now. So I have to bring them back, retest them. And then these patients, they're like needles in haystacks, right? We combed the records of all Mass General Brigham to find these 22 penicillin allergics. We really need to say, OK, you reacted to penicillin in front of my face today.

Grab your blood and then send it to be able to know that they were true positives.

Grab your blood and then send it to be able to know that they were true positives.

Grab your blood and then send it to be able to know that they were true positives.

Slowly.

Slowly.

Slowly.

One of my mentors said to me, if you do your job well, you have no job. And I'm like, I just don't think that's going to happen. There's always something else. We need better tests now, back to the basic science in the lab. And then on the population level, we're thinking about implementing penicillin allergy evaluation in primary care.

One of my mentors said to me, if you do your job well, you have no job. And I'm like, I just don't think that's going to happen. There's always something else. We need better tests now, back to the basic science in the lab. And then on the population level, we're thinking about implementing penicillin allergy evaluation in primary care.

One of my mentors said to me, if you do your job well, you have no job. And I'm like, I just don't think that's going to happen. There's always something else. We need better tests now, back to the basic science in the lab. And then on the population level, we're thinking about implementing penicillin allergy evaluation in primary care.

We just created a measure of delabeled patients in our healthcare system. And even just now that I can measure it, I can measure it in this clinic and that clinic, and I can see what types of interventions move the needle towards a higher percentage of delabeled patients.

We just created a measure of delabeled patients in our healthcare system. And even just now that I can measure it, I can measure it in this clinic and that clinic, and I can see what types of interventions move the needle towards a higher percentage of delabeled patients.

We just created a measure of delabeled patients in our healthcare system. And even just now that I can measure it, I can measure it in this clinic and that clinic, and I can see what types of interventions move the needle towards a higher percentage of delabeled patients.